
Euroapi S.A.S.U (EAPI) | Financial Analysis & Statements
Euroapi S.A.S.U. | Mid-cap | Healthcare
Euroapi S.A.S.U. | Mid-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
1.5B
Total Liabilities
506.0M
Shareholders Equity
983.5M
Debt to Equity
0.51
Cash Flow Metrics
Revenue & Profitability Trend
Euroapi S.A.S.U Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 919.2M | 1.0B | 980.9M | 892.8M | 944.6M |
Cost of Goods Sold | 776.8M | 854.3M | 804.0M | 783.7M | 854.1M |
Gross Profit | 142.4M | 164.6M | 176.9M | 109.1M | 90.4M |
Gross Margin % | 15.5% | 16.2% | 18.0% | 12.2% | 9.6% |
Operating Expenses | |||||
Research & Development | 25.8M | 29.6M | 21.8M | 17.0M | 19.9M |
Selling, General & Administrative | 127.0M | 130.9M | 128.2M | 89.4M | 69.6M |
Other Operating Expenses | - | - | - | 5.4M | 10.6M |
Total Operating Expenses | 152.8M | 160.5M | 150.0M | 111.8M | 100.1M |
Operating Income | -8.4M | 4.5M | 27.1M | 1.5M | -8.4M |
Operating Margin % | -0.9% | 0.4% | 2.8% | 0.2% | -0.9% |
Non-Operating Items | |||||
Interest Income | 9.0M | 2.5M | 8.2M | 200.0K | 1.0M |
Interest Expense | 28.1M | 10.9M | 4.2M | 2.1M | 1.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -139.6M | -242.7M | 3.1M | -14.6M | -11.8M |
Income Tax | -9.0M | -53.0M | 18.2M | -6.5M | -5.5M |
Effective Tax Rate % | 0.0% | 0.0% | 587.1% | 0.0% | 0.0% |
Net Income | -130.6M | -189.7M | -15.1M | -8.1M | -6.3M |
Net Margin % | -14.2% | -18.6% | -1.5% | -0.9% | -0.7% |
Key Metrics | |||||
EBITDA | 77.2M | 309.8M | 129.7M | 77.8M | 64.0M |
EPS (Basic) | - | €-2.02 | €-0.16 | €-0.09 | €-0.07 |
EPS (Diluted) | - | €-2.02 | €-0.16 | €-0.09 | €-0.07 |
Basic Shares Outstanding | - | 94200000 | 93700000 | 94026888 | 94026888 |
Diluted Shares Outstanding | - | 94200000 | 93700000 | 94026888 | 94026888 |
Income Statement Trend
Euroapi S.A.S.U Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 73.0M | 34.5M | 74.5M | 10.3M | 100.0K |
Short-term Investments | - | 8.4M | 4.8M | 19.0M | 153.8M |
Accounts Receivable | 161.3M | 216.2M | 264.2M | 238.9M | 194.7M |
Inventory | 524.2M | 644.8M | 594.8M | 569.5M | 584.1M |
Other Current Assets | 44.6M | 200.0K | -100.0K | 86.3M | 8.4M |
Total Current Assets | 830.3M | 979.3M | 1.0B | 905.0M | 983.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 529.3M | 8.8M | 6.8M | 631.7M | 1.5B |
Goodwill | 38.1M | 43.4M | 28.6M | 26.8M | 5.4M |
Intangible Assets | 38.1M | 34.2M | 28.6M | 26.8M | 5.4M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 4.6M | 8.9M | 14.9M | 9.7M | - |
Total Non-Current Assets | 659.2M | 633.1M | 712.5M | 717.0M | 617.5M |
Total Assets | 1.5B | 1.6B | 1.7B | 1.6B | 1.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 104.9M | 159.6M | 219.6M | 189.6M | 131.1M |
Short-term Debt | 55.9M | 210.0M | 104.6M | 5.4M | 58.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 152.5M | 9.7M | 10.1M | 191.7M | 54.7M |
Total Current Liabilities | 328.5M | 508.9M | 456.5M | 386.7M | 365.3M |
Non-Current Liabilities | |||||
Long-term Debt | 13.2M | 15.5M | 16.2M | 18.7M | 15.4M |
Deferred Tax Liabilities | 0 | 1.6M | 6.3M | 5.6M | 11.2M |
Other Non-Current Liabilities | -100.0K | - | - | 100.0K | 100.0K |
Total Non-Current Liabilities | 177.5M | 175.7M | 169.4M | 219.4M | 246.3M |
Total Liabilities | 506.0M | 684.6M | 625.9M | 606.1M | 611.6M |
Equity | |||||
Common Stock | - | 95.1M | 94.6M | 90.0M | 90.0M |
Retained Earnings | - | - | - | - | - |
Treasury Stock | - | 1.9M | 1.3M | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 983.5M | 927.8M | 1.1B | 1.0B | 989.4M |
Key Metrics | |||||
Total Debt | 69.1M | 225.5M | 120.8M | 24.1M | 73.4M |
Working Capital | 501.8M | 470.4M | 567.1M | 518.3M | 618.3M |
Balance Sheet Composition
Euroapi S.A.S.U Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -130.6M | -189.7M | -15.0M | -8.1M | -6.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | 1.8M | 1.6M |
Working Capital Changes | 202.6M | -15.8M | -87.8M | -66.5M | 22.3M |
Operating Cash Flow | 101.8M | -191.8M | -89.4M | -73.3M | 17.2M |
Investing Activities | |||||
Capital Expenditures | -108.0M | -132.8M | -167.4M | -87.9M | -88.3M |
Acquisitions | - | -4.5M | 0 | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -108.0M | -137.3M | -167.4M | -87.9M | -88.3M |
Financing Activities | |||||
Share Repurchases | -100.0K | -600.0K | -1.3M | 0 | - |
Dividends Paid | - | - | - | - | -4.7M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 42.9M | 105.6M | 195.3M | 29.0M | -5.8M |
Free Cash Flow | 14.9M | -127.7M | -122.6M | -17.1M | 8.4M |
Net Change in Cash | 36.7M | -223.5M | -61.5M | -132.2M | -76.9M |
Cash Flow Trend
Euroapi S.A.S.U Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.84
Forward P/E
-26.42
Price to Book
0.40
Price to Sales
0.34
PEG Ratio
-26.42
Profitability Ratios
Profit Margin
-14.08%
Operating Margin
3.21%
Return on Equity
-13.49%
Return on Assets
-0.67%
Financial Health
Current Ratio
2.53
Debt to Equity
7.17
Beta
0.68
Per Share Data
EPS (TTM)
€-1.38
Book Value per Share
€7.91
Revenue per Share
€9.33
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
eapi | 301.9M | 8.84 | 0.40 | -13.49% | -14.08% | 7.17 |
Ipsen S.A | 9.5B | 21.49 | 2.26 | 10.89% | 11.91% | 22.74 |
Vetoquinol S.A | 887.3M | 15.10 | 1.54 | 10.64% | 10.88% | 3.67 |
Boiron S.A | 392.4M | 34.77 | 1.04 | 2.95% | 2.33% | 3.96 |
AB Science S.A | 83.1M | -8.60 | - | 32.97% | 116.42% | -0.78 |
CoreTech Limited | 3.0M | - | - | -102.42% | 137.36% | -0.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.